In addition, the results of immunohistochemistry (IHC) staining of CRC samples and adjacent para-cancer tissue further verified that METTL16 expression was enhanced in CRC tissues (Fig. 1M and N). The gene discussed is METTL16; the disease is colorectal carcinoma.